Lesson
Build the Disease Model
Seborrheic dermatitis reflects an interaction among sebum-rich skin, Malassezia, barrier function, individual susceptibility, and inflammation. Dandruff is the milder scalp-predominant end of the spectrum.
- Sebum-rich sites
- Malassezia
- Barrier function
- Inflammation
- Relapse
Scalp, face, ears, and chest
A normal resident in an altered host response
Turnover and lipid disruption amplify symptoms
Control and maintenance have different jobs
Reject the hygiene myth
Seborrheic dermatitis is not caused by being dirty and is not contagious. Harsh washing can injure the barrier and worsen a flare.
Place Malassezia correctly
Malassezia normally lives on human skin. The disease reflects host response and local ecology, not a simplistic claim that every patient has an infection.
Map the distribution
The scalp, brows, glabella, nasolabial folds, ears, beard area, central chest, and folds are common because they are sebum-rich or occluded.
Expect recurrence
Treatment can control scale, itch, and inflammation, but it does not permanently change susceptibility. Maintenance is often part of successful care.
Quick check
Checking for saved practice…
Lesson
Recognize the Pattern and Its Mimics
Morphology, distribution, age, hair findings, systemic symptoms, and host status determine whether a familiar flare can be treated or needs diagnosis.
- Scalp scale
- Facial folds
- Psoriasis
- Tinea capitis
- Red flags
Dandruff is the mild scalp end
Vehicle and steroid risk change
Hair loss or pustules change the diagnosis
Do not self-treat a dangerous pattern
Read the whole pattern
Scalp scale may be fine and white or greasy. Inflammation may look red, pink or violet. Affected skin may also be darker or lighter than surrounding skin; pigment change is not the same finding as erythema.
Compare common mimics
Well-demarcated thick plaques suggest psoriasis. Annular lesions, broken hairs, alopecia, pustules, or lymphadenopathy raise concern for tinea capitis or another infection.
Do not mask scalp ringworm
Suspected tinea capitis needs diagnostic evaluation and usually an oral antifungal; shampoo alone is not curative treatment. A steroid can suppress redness while allowing fungal disease to worsen. Do not treat a new, undiagnosed scaly eruption with steroid rescue by assumption.
Inspect exposures
New dyes, fragrances, oils, adhesives, cosmetics, and topical medicines can cause irritant or allergic contact dermatitis. Ask which products accompany a protective style rather than assuming the style itself is an allergen.
Escalate atypical disease
Pain, fever, purulence, scarring, rapid hair loss, eye pain, widespread eruption, immune compromise, or persistent failure requires clinical assessment.
Quick check
Checking for saved practice…
Lesson
Engineer a Scalp Shampoo Plan
Medicated shampoo is an active treatment, not ordinary hair washing. The ingredient, schedule, contact time, hair texture, and ability to reach the scalp determine success.
- Ketoconazole
- Ciclopirox
- Selenium sulfide
- Pyrithione zinc
- Keratolytics
Reduce the yeast-linked disease signal
Follow the exact label
Useful for selected thick scale
Leave on only as directed, then rinse
Specify ketoconazole 1 percent
Nizoral 1% Drug Facts directs patients age 12 and older to wet hair, lather, rinse and repeat every 3 to 4 days for up to eight weeks, then as needed. It does not specify a five-minute hold. Under age 12, or during pregnancy or breastfeeding, ask a clinician. Do not use on a broken or inflamed scalp; stop for rash, worsening or no improvement within 2 to 4 weeks.
Specify ciclopirox 1 percent
For adult scalp seborrheic dermatitis, wet hair and apply about 5 mL; long hair may need up to 10 mL. Lather for three minutes, then rinse. Repeat twice weekly for four weeks, spacing applications at least three days apart. Reassess the diagnosis if there is no improvement after four weeks. Stop for irritation; light hair can discolor.
Separate indication from study ages
The cited ciclopirox label states an adult indication. Trials enrolled patients age 16 and older; safety and effectiveness below 16 are unestablished. Trial eligibility alone does not define an approved pediatric indication.
Distinguish prescription shampoo use
The cited U.S. ketoconazole 2% shampoo label is for tinea versicolor, with a single five-minute application. Its use for scalp seborrheic dermatitis is off-label and needs a clinician-specified regimen; do not transfer the tinea-versicolor course or the OTC 1% instructions.
Use OTC actives deliberately
Selenium sulfide and pyrithione zinc can reduce itching, flaking, scaling, irritation, and recurrence when used according to the specific label.
Read rinsing instructions separately
The cited selenium sulfide 1% product directs shaking, wetting hair, scalp massage and rinsing, with use at least twice weekly or as directed. For bleached, gray, tinted or permed hair, it specifies at least five minutes of rinsing. That is rinse time, not a five-minute medicated hold.
Use scale-directed options selectively
Salicylic acid can loosen scale. Coal tar can reduce scale and turnover but may smell, stain, discolor light hair, or increase photosensitivity. The cited coal tar label warns of increased sunburn risk for up to 24 hours and requires clinician direction before combining with UV treatment or other psoriasis therapy.
Respect hair practice
Apply to the scalp rather than coating only the hair. A plan for tightly coiled hair may use a less frequent schedule while preserving adequate contact and maintenance.
Quick check
Checking for saved practice…
Lesson
Treat Skin Outside the Scalp
Facial, ear, beard, chest, and fold disease needs a vehicle that reaches affected skin without unnecessary ocular, mucosal, or irritant exposure.
- Ketoconazole cream
- Foam and gel
- Facial disease
- Folds
- Local tolerance
Thin application to affected skin
Vehicle can improve reach and adherence
External-use instructions still matter
Irritation can mimic a flare
Choose a skin vehicle
Creams suit localized glabrous skin. Foams and gels can help hair-bearing areas, but products with the same ingredient may have different ages, schedules, and approved uses.
Compare ketoconazole courses
For seborrheic dermatitis, the cited 2% cream label uses twice-daily treatment for four weeks or until clearing. Ketoconazole 2% foam uses twice-daily treatment for four weeks; Xolegel 2% gel uses once-daily treatment for two weeks. Foam and gel labeling specifies immunocompetent patients age 12 and older; the cream label does not establish pediatric safety and efficacy.
Handle foam and gel safely
Dispense ketoconazole foam with the can upright into its cap or onto a cool surface, then use fingertips to rub it into affected skin. Part hair to reach the skin; wash hands afterward. Both foam and gel are flammable: avoid fire, smoking and flame during and immediately after application.
Protect the gel application
For Xolegel, wash hands before and after use. Do not wash the treated area for at least three hours, and wait at least 20 minutes before applying sunscreen or makeup there. These are gel-specific instructions, not shampoo contact times.
Apply a thin layer
More product does not guarantee more effect. Extend only to the affected area and follow the exact label or clinician plan.
Protect sensitive boundaries
Keep topical antifungals away from eyes and mucosa unless the product is specifically designed for that site. Eyelid-margin disease deserves careful evaluation.
Distinguish irritation from disease
Burning, stinging, erythema, dryness, or contact dermatitis can follow topical treatment. Reassess a worsening site instead of repeatedly increasing exposure.
Quick check
Checking for saved practice…
Lesson
Control Inflammation Without Creating a New Problem
Inflammation can persist after antifungal therapy. Short rescue treatment should be separated from safer long-term maintenance.
- Topical corticosteroids
- Potency
- Face and folds
- Calcineurin inhibitors
- Exit strategy
Potency, site, and duration govern risk
Avoid prolonged unsupervised use
Off-label clinician-directed option
Do not let rescue therapy become routine
Use steroids as rescue
A low-potency topical corticosteroid can rapidly reduce itch and inflammation during a flare. Potency, vehicle, site, age, area, and duration determine safety.
Protect thin skin
Prolonged or potent corticosteroid use on the face, eyelids, ears, or folds can cause atrophy, telangiectasia, pigment change, acneiform eruption, and ocular harm.
Consider a steroid-sparing route
Clinician-directed tacrolimus or pimecrolimus can reduce inflammation on sensitive sites without steroid atrophy, but seborrheic dermatitis use is off-label and transient burning is common.
Explain calcineurin-inhibitor precautions
These products carry a boxed warning: rare skin cancers and lymphoma have been reported, without an established causal relationship, and continuous long-term use should be avoided. Pimecrolimus labeling excludes immunocompromised patients, calls for resolving treatment-site bacterial or viral infections, and advises minimizing natural and artificial UV exposure. Off-label use still needs a defined duration and follow-up.
Define the exit
A rescue medicine should have a stop point. Continued prevention usually returns to antifungal, gentle skin care, or another maintenance plan.
Quick check
Checking for saved practice…
Lesson
Use Topical PDE4 Inhibition Precisely
Roflumilast foam offers once-daily nonsteroidal treatment for scalp and body disease, but it still requires exact indication, age, liver, interaction, and flammability screening.
- PDE4
- Cyclic AMP
- Foam 0.3 percent
- Once daily
- Liver impairment
Raises intracellular cyclic AMP
Exact therapeutic mechanism is not fully defined
Scalp and body application
Liver impairment and flammability matter
Connect target to effect
Roflumilast and its active metabolite inhibit PDE4, allowing intracellular cyclic AMP to accumulate. This supports an anti-inflammatory treatment model, but the label states that the precise therapeutic mechanism is not well defined.
Use the approved population
Current labeling indicates roflumilast foam 0.3 percent for seborrheic dermatitis in adults and pediatric patients at least 9 years old.
Apply correctly
Shake the can, turn it completely upside down, and dispense a small amount into your hand. Part hair to reach affected scalp. Apply a thin layer once daily when skin is not wet, rub in completely, and wash hands afterward. Store upright at room temperature; do not freeze, puncture or expose the pressurized can to excessive heat.
Screen label hazards
Child-Pugh B or C liver impairment contraindicates the foam; Child-Pugh A does not require a dose adjustment. Avoid flame and smoking during and immediately after application. Systemic CYP3A4 inhibitors, combined CYP3A4/CYP1A2 inhibitors, and gestodene/ethinyl-estradiol contraceptives can increase exposure; weigh adverse-effect risk against benefit.
Address pregnancy and infant exposure
Human pregnancy and milk data are insufficient. Avoid use during labor and delivery. During breastfeeding, use the smallest area for the shortest necessary time, never the nipple or areola, and prevent infant skin contact with a treated chest.
Monitor tolerability
Seborrheic-dermatitis trials reported nasopharyngitis, nausea and headache in at least 1% of treated patients. Topical delivery does not remove systemic safety considerations.
Quick check
Checking for saved practice…
Lesson
Adapt Treatment to the Patient
Age, skin tone, hair texture, pregnancy, lactation, immune status, and neurologic disease change recognition, feasibility, evidence, and referral thresholds.
- Cradle cap
- Skin of color
- Tightly coiled hair
- Pregnancy and lactation
- High-risk host
Gentle scale care, no adult shampoo assumption
Build a feasible scalp schedule
Track pigment change and texture
Lower the threshold for evaluation
Care for cradle cap gently
Infantile seborrheic dermatitis is often self-limited. Use fragrance-free baby shampoo and gently remove loosened scale with a soft baby brush. For adherent scale, a non-food-based baby oil can soften it before washing; do not pick or scrape. Adult dandruff shampoo is not a default infant treatment. Pain, hair loss, odor, a severe spreading rash, or worsening needs assessment; fever or poor feeding requires prompt pediatric evaluation.
Recognize across skin tones
Inflammation may be less visibly red and can leave hypo- or hyperpigmentation. Track texture, scale, itch, and pigment rather than relying on redness alone.
Respect hair structure and styling
Tightly coiled hair and protective styles may make frequent washing impractical or damaging. Agree on an effective schedule and vehicle rather than labeling the patient nonadherent.
Individualize higher-risk decisions
Use product-specific pregnancy and lactation data, age labeling, treated area, infant contact, immune status, and neurologic disease. Avoid retired pregnancy letters.
Quick check
Checking for saved practice…
Lesson
Turn the Label Into Safe Technique
Dandruff products differ in active ingredient, concentration, schedule, contact time, staining, irritation, photosensitivity, broken-skin warnings, and age limits.
- Active ingredient
- Contact time
- Eye exposure
- Hair discoloration
- Duplication
Avoid accidental duplication
Use product-specific contact time
Warnings vary by formulation
Stop or adjust when harm exceeds benefit
Identify the active
Brand families may sell multiple formulas. Confirm the active ingredient and strength before judging response or combining products.
Use product-specific contact
Wet or dry application, massage, contact time, rinse, frequency, and treatment length vary. A universal five-minute rule is unsafe.
Protect eyes and injured skin
External-use products can irritate eyes and broken or inflamed skin. Rinse eye exposure thoroughly and follow the product's warning language.
Anticipate cosmetic effects
Selenium sulfide and coal tar products can discolor some hair or stain materials. Tar can also increase photosensitivity. Discuss acceptability before prescribing the routine.
Quick check
Checking for saved practice…
Lesson
Build Control That Survives the Next Flare
Successful care measures symptoms and function, distinguishes induction from maintenance, and rechecks diagnosis, technique, adherence, and exposures when control fails.
- Induction
- Maintenance
- Trigger tracking
- Monitoring
- Referral
Start with an active regimen
Relapse is expected, not failure
Follow function as well as appearance
Recheck diagnosis, technique, and adherence
Define the phases
Induction suppresses active scale and inflammation. Maintenance may use intermittent medicated shampoo or another clinician-directed regimen after control.
Track meaningful outcomes
Record sites, itch, scale, pain, sleep, embarrassment, styling burden, pigment change, treatment tolerance, and recurrence rather than appearance alone.
Audit apparent failure
Confirm diagnosis, active ingredient, expiration, technique, contact time, schedule, site access, hair routine, new products, and adherence before escalating.
Know when to refer
Refer persistent, widespread, painful, infected, scarring, alopecic, ocular, immunocompromised, or diagnostically uncertain disease. Infants with uncomplicated cradle cap can receive gentle care; atypical, severe, worsening or symptomatic infant eruptions need assessment. Abrupt severe disease can justify evaluation for an associated condition.
Quick check
Checking for saved practice…
Module practice
Check the connections.
Each attempt draws 10 questions from the complete 117 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Core source material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.
- AAD Cradle Cap Care and Referral
- DailyMed Pimecrolimus Prescribing Information
- DailyMed Tacrolimus Ointment Prescribing Information
- CDC Ringworm Treatment: Scalp Disease and Steroid Precautions
- DailyMed Coal Tar Shampoo Drug Facts
- DailyMed T/Sal 3% Salicylic Acid Drug Facts
- DailyMed Pyrithione Zinc 1% Drug Facts
- Ketoconazole 2% Cream Prescribing Information
- Ketoconazole 2% Foam Prescribing Information
- Xolegel Prescribing Information
- AAD Seborrheic Dermatitis Diagnosis and Treatment
- AAD Seborrheic Dermatitis Self-Care
- AAD Seborrheic Dermatitis Signs and Symptoms
- DailyMed Roflumilast Foam 0.3 Percent
- DailyMed Selenium Sulfide 1 Percent Shampoo
- DailyMed Ketoconazole 2 Percent Shampoo
- DailyMed Ciclopirox 1 Percent Shampoo
- DailyMed Nizoral Ketoconazole 1 Percent Drug Facts